Akouos

Focus: Akouos is a gene therapy biotech focused on developing treatments for hearing disorders, headquartered in Boston. The company operates in the specialized and emerging segment of otologic gene therapy.

Gene Therapy

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Akouos

AI assessmentNot Hiring

No open roles listed right now. Follow Akouos to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

5 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy

Vestibular Schwannoma

N/A

Clinical Trials (1)

NCT07503613Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy

N/A

Help build intelligence for Akouos

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to work in an emerging therapeutic area (gene therapy for hearing) with limited competition and high unmet medical need
Boston location provides access to world-class research institutions, talent networks, and biotech ecosystem
Early-stage biotech environment offers potential for significant equity upside and meaningful individual impact on product development

Watch Out For

No active clinical trials reported, indicating early-stage development with extended timelines to regulatory milestones and revenue
Zero active job openings suggest the company may be in growth pause, restructuring, or pre-financing mode with limited near-term hiring

Generated by Claude from Akouos's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy

Otoferlin Gene-mediated Hearing Loss

N/A

Clinical Trials (1)

NCT06696456Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy

N/A

Natural History Study

Sensorineural Hearing Loss, Bilateral

N/A

Clinical Trials (1)

NCT05572073Otoferlin Gene-mediated Hearing Loss Natural History Study

N/A

AAVAnc80-antiVEGF via Akouos Delivery Device

Vestibular Schwannoma

Phase 1/2

Clinical Trials (1)

NCT06517888Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Phase 1/2

AAVAnc80-hOTOF via Akouos Delivery Device

Sensorineural Hearing Loss, Bilateral

Phase 1/2

Clinical Trials (1)

NCT05821959Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss

Phase 1/2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 5 clinical trials

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo